A revolutionary gene therapy is offering new hope for individuals born with profound deafness, potentially restoring their ability to hear within a matter of weeks. In a small yet groundbreaking clinical trial, researchers successfully delivered a functional copy of a crucial hearing gene directly into the inner ear through a single, targeted injection. All ten participants in the study, ranging from young children to adults, demonstrated significant improvements in their hearing, with some reporting remarkable progress and auditory gains in as little as one month.

